Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Meritage Homes Corporation (MTH.N)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-02-1546.8878.00Buy
2022-06-1633.4155.00Buy
2022-07-2844.1660.00Buy
2022-10-2737.1056.50Buy
2023-01-0548.9262.00Buy
2023-02-0258.3072.50Buy
2023-04-2761.1277.50Buy
2023-07-3174.4894.00Buy
2023-10-0260.3285.00Buy
2023-10-1856.3084.00Buy
2024-01-0483.16109.50Buy
2024-04-2582.54116.00Buy
2024-07-2596.58119.50Buy
2024-10-3088.77126.00Buy
2025-01-0876.23118.00Buy
2025-04-2468.92107.00Buy

Disclosures

  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.